Very late stent thrombosis in a drug-eluting stent due to interruption of anti-platelet agents in patients with acute myocardial infarction and thrombocytosis

Korean Circulation Journal

Volumn 41, Issue 7, 2011, Pages 417-420

  Choi, Hong Sang ^a   Jeong, Myung Ho ^a   Seo, Kook Il ^a   Lee, Min Goo ^a   Ko, Jum Suk ^a   Park, Keun Ho ^a   Sim, Doo Sun ^a   Yoon, Nam Sik ^a   Kim, Kye Hun ^a   Park, Hyung Wook ^a   Hong, Young Joon ^a   Kim, Ju Han ^a   Ahn, Youngkeun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Drug eluting stents; Essential thrombocythemia; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANAGRELIDE; CILOSTAZOL; CLOPIDOGREL; CLOTINAB; COROFLEX BLUE; CYPHER; HYDROXYUREA; RAPAMYCIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD PRESSURE; BONE MARROW BIOPSY; BREATHING RATE; CASE REPORT; CLINICAL EXAMINATION; CORONARY ARTERY CIRCUMFLEX BRANCH; DRUG ELUTING STENT; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ENDOSCOPY; FEMALE; FOLLOW UP; HEART RATE; HEMATOCRIT; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; OXYGEN SATURATION; PERCUTANEOUS CORONARY INTERVENTION; PHLEBOTOMY; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TEMPERATURE; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOPHERESIS; THROMBOCYTOSIS; TREATMENT DURATION; TREATMENT WITHDRAWAL; VERY LATE STENT THROMBOSIS;

EID: 80052009928     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.7.417     Document Type: Article

References (20)

1. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108:788-94. (Pubitemid 37022118)
2. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VEIocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798-803.
3. Zhang F, Ge J, Qian J, et al. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 2007;48:303-11. (Pubitemid 47181003)
4. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78. (Pubitemid 46281313)
5. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356: 1030-9. (Pubitemid 46376803)
6. Pinto Slottow TL, Steinberg DH, Roy PK, et al. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol 2008;102:298-303.
7. Spaulding C, Daemen J, Boersma E, Cuttlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-97:
8. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
9. Kim SS, Jeong MH, Sim DS, et al. Very late thrombosis of a drug-eluting stent after discontinuation of dual antiplatelet therapy in a patient treated with both drug-eluting and bare-metal stents. Korean Circ J 2009;39:205-8.
10. Awata M, Kotani J, Uematsu M, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 2007;116: 910-6. (Pubitemid 47300915)
11. Takano M, Yamamoto M, Xie Y, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart 2007;93:1353-6. (Pubitemid 351480129)
12. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
13. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006;113:1108-13.
14. Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006;98:352-6.
15. Veitch AM, Baglin TP, Gershlick AH, et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008;57:1322-9.
16. Zuckerman MJ, Hirota WK, Adler DG, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005;61: 189-94. (Pubitemid 40261064)
17. Tefferi A, Fonseca R, Pereira DL, Hoagland HC. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc 2001;76:22-8. (Pubitemid 32042994)
18. Turgut T, Harjai KJ, Edupuganti R, et al. Acute coronary occlusion and in-stent thrombosis in a patient with essential thrombocythemia. Cathet Cardiovasc Diagn 1998;45:428-33. (Pubitemid 28541738)
19. Watanabe T, Fujinaga H, Ikeda Y, et al. Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting: a case report. Angiology 2005;56:771-4. (Pubitemid 41790987)
20. Kumagai N, Mitsutake R, Miura S, et al. Acute coronary syndrome associated with essential thrombocythemia. J Cardiol 2009;54:485-9.